ELIZABETH CZEREPAK

Insider Reports History

Location
Rutherford, NJ
Signature
/s/ Thomas A. Fitzgerald, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by ELIZABETH CZEREPAK:

Company Role Class Num Shares Value Price $ Report Date Ownership
Scilex Holding Co Executive Vice President, Chief Business Officer and Chief Financial Officer Nonstatutory Stock Option (right to buy) 350,000 17 Jan 2023 Direct
Sorrento Therapeutics, Inc. EVP & Chief Financial Officer Stock Option (right to buy) 350,000 18 May 2022 Direct
DELCATH SYSTEMS, INC. Director Stock Option (right to buy) 22,500 15 May 2025 Direct

Insider Reports Filed by ELIZABETH CZEREPAK

Symbol Company Period Transactions Value $ Form Type Role Filing Time
RNAZ Transcode Therapeutics, Inc. 06 Oct 2025 0 $0 3 Director 22 Dec 2025, 16:39
DCTH DELCATH SYSTEMS, INC. 15 May 2025 1 $0 4 Director 19 May 2025, 16:10
DCTH DELCATH SYSTEMS, INC. 23 May 2024 1 $0 4 Director 28 May 2024, 16:32
DCTH DELCATH SYSTEMS, INC. 12 Jun 2023 1 $0 4 Director 21 Jun 2023, 21:18
SCLX Scilex Holding Co 17 Jan 2023 1 $0 4 Executive Vice President, Chief Business Officer and Chief Financial Officer 17 Jan 2023, 16:25
SCLX Vickers Vantage Corp. I 10 Nov 2022 0 $0 3 Officer 15 Nov 2022, 17:29
/report/000120919122031081-czerepak-elizabeth-2022-05-18 Sorrento Therapeutics, Inc. 18 May 2022 1 $0 4 EVP & Chief Financial Officer 20 May 2022, 17:14
DCTH DELCATH SYSTEMS, INC. 04 May 2022 1 $0 4 Director 06 May 2022, 13:45
/report/000120919121065539-czerepak-elizabeth-2021-11-18 Sorrento Therapeutics, Inc. 18 Nov 2021 1 $0 4 Director 18 Nov 2021, 16:11
/report/000120919121065532-czerepak-elizabeth-2021-11-15 Sorrento Therapeutics, Inc. 15 Nov 2021 0 $0 3 Director 18 Nov 2021, 16:08
DCTH DELCATH SYSTEMS, INC. 05 Aug 2021 1 $0 4 Director 09 Aug 2021, 16:36